Tesamorelin

GHRH analogue. FDA-approved for HIV-associated lipodystrophy. Reduces visceral fat significantly.

✅ Potential Benefits

FDA-approved peptide — established safety profile
Significantly reduces visceral (abdominal) fat
Increases IGF-1 and GH levels
Improves body composition
Cognitive benefits studied in older adults
Reduces inflammatory markers

💊 Dosing Protocol

2mg SubQ daily (FDA-approved dose). Rotate injection sites.

⏱ Half-Life

~26 minutes

⚠️ Common Side Effects

Injection site reactions, edema, arthralgia, carpal tunnel syndrome, glucose intolerance.

🚫 Warnings & Contraindications

FDA approved but only for specific indication — off-label use is research only
May increase blood glucose — monitor in diabetics or pre-diabetics
Active malignancy contraindication
Discontinue if IGF-1 exceeds normal range

🚨 Adverse Effects

Hyperglycemia, fluid retention, carpal tunnel syndrome, peripheral edema. Potential for IGF-1 driven tumor growth.

📬 Interested in Tesamorelin?

Have questions about this peptide or want to discuss availability?

✉️ Send an Inquiry

⚕️ This information is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before beginning any wellness protocol.

Track your Tesamorelin protocol in the app

Calculate exact doses, schedule injections, journal your progress.

🚀 Try Free for 7 Days